The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer.
Standard
The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer. / Pantel, Klaus; Alix-Panabières, Catherine.
In: CANCER DISCOV, Vol. 2, No. 11, 11, 2012, p. 974-975.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer.
AU - Pantel, Klaus
AU - Alix-Panabières, Catherine
PY - 2012
Y1 - 2012
N2 - Miyamoto and colleagues present data that prostate-specific antigen/prostate-specific membrane antigen (PSA/PSMA)-based measurements of androgen receptor (AR) signaling in circulating tumor cells (CTC) enable real-time quantitative monitoring of intratumoral AR signaling. This finding indicates that measuring AR signaling within CTCs may help to guide therapy in metastatic prostate cancer and highlights the use of CTCs as liquid biopsy.
AB - Miyamoto and colleagues present data that prostate-specific antigen/prostate-specific membrane antigen (PSA/PSMA)-based measurements of androgen receptor (AR) signaling in circulating tumor cells (CTC) enable real-time quantitative monitoring of intratumoral AR signaling. This finding indicates that measuring AR signaling within CTCs may help to guide therapy in metastatic prostate cancer and highlights the use of CTCs as liquid biopsy.
KW - Humans
KW - Male
KW - Tumor Markers, Biological/metabolism
KW - Neoplasms, Hormone-Dependent/metabolism
KW - Neoplastic Cells, Circulating/metabolism
KW - Prostatic Neoplasms/metabolism
KW - Receptors, Androgen/metabolism
KW - Humans
KW - Male
KW - Tumor Markers, Biological/metabolism
KW - Neoplasms, Hormone-Dependent/metabolism
KW - Neoplastic Cells, Circulating/metabolism
KW - Prostatic Neoplasms/metabolism
KW - Receptors, Androgen/metabolism
M3 - SCORING: Journal article
VL - 2
SP - 974
EP - 975
JO - CANCER DISCOV
JF - CANCER DISCOV
SN - 2159-8274
IS - 11
M1 - 11
ER -